Singapore, 25 June 2020 — Zagro Asia Limited has recently conducted testing of its key disinfectant, Ultraxide™, against African Swine Fever (ASF). Zagro believes that at this point in time, only a sound biosecurity measure is feasible against ASF, with no vaccine nor other medical treatment currently available.
Zagro Asia Limited had commissioned for independent evaluation of Ultraxide™ against the ASF virus in Spain, in accordance with the EN 14675 test method, which was modified to enable testing against the ASF virus. CISA is the European Union reference laboratory for ASF since 2002.
Ultraxide™ had achieved complete inactivation of the ASF virus at a 1:300, 1:200, and at 1:100 dilution rate at the exposure time of 5 minutes.
The test method employed included the presence of organic matter and hard water, and the test was conducted at low temperature (10˚ C) in order to assess Ultraxide™’s performance and suitability for use in various farm set ups across the continent.
The results provided confirmation of the efficacy of Ultraxide™ in deactivating the African Swine Fever virus rapidly, not only in a laboratory set up but also in real life farm settings.
Zagro Asia Limited is a leader in agrisolutions with footprints in more than 70 countries. Extensively used in farming communities worldwide, the company’s range of disinfectants, specifically Ultraxide™, are tested to destroy animal viruses.
As part of Zagro’s commitment to providing biosecurity solution and support for ASF control with Ultraxide™, Zagro’s team of veterinarians can be contacted via email (firstname.lastname@example.org) or via Whatsapp (+65 9653 1942).